Interview with Martin Jönsson CEO of AlzeCure Pharma

23 September 2022 - 14:46
Finwire interviewed Martin Jönsson CEO at AlzeCure Pharma. Martin talks about patent approval, clinical studies, new data and why investors should take a closer look at AlzeCure Pharma. Don't forget to subscribe to the channel to take part in more interesting company films, interviews and presentations....
Nasdaq First North GM Stockholm (Sweden)
AlzeCure Pharma AB
AlzeCure Pharma is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops five drug candidates within its two research platforms NeuroRestore and Alzstatin....
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More